Related Experiment Video
Updated: Jun 7, 2025

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Mechanisms and Screening for Atherosclerosis in Adults With Vasculitis
Michael J Hendrickson1, Zachary S Wallace1,2
1Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (M.J.H., Z.S.W.).
Insights
Vascular inflammation in systemic vasculitis contributes to cardiovascular events via direct cardiac issues and accelerated atherosclerosis. More research is needed on screening and management for these patients.
Area of Science:
- Rheumatology
- Cardiology
- Immunology
Background:
- Vascular inflammation is central to systemic vasculitis and atherosclerosis.
- Cardiovascular events are frequent in vasculitis patients due to direct vascular inflammation and accelerated atherosclerosis.
- Cardiac involvement is noted across vasculitides, particularly Takayasu arteritis, polyarteritis nodosa, and eosinophilic granulomatosis with polyangiitis.
Purpose of the Study:
- To review current evidence on epidemiology, mechanisms, and screening for atherosclerosis in primary systemic vasculitis.
- To highlight the need for evidence-based guidelines for cardiovascular risk management in vasculitis.
Main Methods:
- Literature review of recent studies on vasculitis and atherosclerosis.
- Analysis of epidemiological data, pathogenic mechanisms, and screening strategies.
- Synthesis of current knowledge regarding cardiovascular risk in primary systemic vasculitis.
Main Results:
- Accelerated atherosclerosis is documented in Takayasu arteritis and antineutrophil cytoplasmic antibody-associated vasculitis.
- Data on atherosclerosis in other vasculitis forms remains limited.
- Existing screening and management strategies lack robust evidence-based guidelines.
Conclusions:
- Cardiovascular risk in vasculitis patients requires comprehensive understanding and management.
- Further research is essential to develop evidence-based guidelines for screening and managing atherosclerosis in primary systemic vasculitis.
- Addressing both direct cardiac involvement and accelerated atherosclerosis is crucial for improving patient outcomes.
Abstract:
Vascular inflammation is a hallmark of both primary systemic vasculitis and atherosclerosis. As such, cardiovascular events are common in patients with vasculitis and likely due to both direct vascular inflammation and accelerated atherosclerosis. Direct cardiac involvement is possible in all vasculitides, though more commonly described in Takayasu arteritis, polyarteritis nodosa, and eosinophilic granulomatosis with polyangiitis. Accelerated atherosclerosis has been described in Takayasu arteritis and antineutrophil cytoplasmic antibody-associated vasculitis, though there remains a paucity of data in other forms of vasculitis. Multiple screening and management approaches for cardiovascular risk in people with vasculitis have been proposed, though evidence-based guidelines are lacking. In this review, we discuss the latest evidence in epidemiology, mechanisms, and screening for atherosclerosis in patients with primary systemic vasculitides.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

